METROPOLITAN LIFE INSURANCE CO/NY - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2021$45,970
-29.8%
16,963
+15.6%
0.00%0.0%
Q3 2021$65,464
-56.2%
14,678
-43.1%
0.00%
-50.0%
Q2 2021$149,576
-9.9%
25,789
+9.1%
0.00%0.0%
Q1 2021$165,995
+32.5%
23,646
-9.4%
0.00%0.0%
Q4 2020$125,266
-15.7%
26,097
+2.4%
0.00%
-33.3%
Q3 2020$148,543
-6.2%
25,479
+8.6%
0.00%0.0%
Q2 2020$158,369
+60.1%
23,462
+50.9%
0.00%
+50.0%
Q1 2020$98,898
-39.0%
15,5500.0%0.00%
-33.3%
Q4 2019$162,109
+165.9%
15,550
+0.2%
0.00%
+200.0%
Q3 2019$60,966
-73.6%
15,5130.0%0.00%
-75.0%
Q2 2019$230,678
-40.1%
15,5130.0%0.00%
-42.9%
Q1 2019$385,033
+38.2%
15,5130.0%0.01%
+16.7%
Q4 2018$278,613
-38.8%
15,5130.0%0.01%
-25.0%
Q3 2018$455,617
-99.9%
15,5130.0%0.01%
-27.3%
Q2 2018$705,377,000
-6.8%
15,513
+8.2%
0.01%0.0%
Q1 2018$757,099,000
+78682.4%
14,339
+1.4%
0.01%
-15.4%
Q4 2017$961,000
-60.2%
14,138
-51.7%
0.01%
-13.3%
Q3 2017$2,414,000
-12.0%
29,2940.0%0.02%
-21.1%
Q2 2017$2,743,000
+69.3%
29,294
+15.1%
0.02%
+72.7%
Q1 2017$1,620,000
+54.7%
25,449
+8.0%
0.01%
+37.5%
Q4 2016$1,047,000
+19.2%
23,566
-3.3%
0.01%
+33.3%
Q3 2016$878,000
+166.1%
24,364
+1.3%
0.01%
+200.0%
Q2 2016$330,000
-10.8%
24,046
+24.9%
0.00%
-33.3%
Q1 2016$370,000
-45.1%
19,2510.0%0.00%
-40.0%
Q4 2015$674,000
-62.5%
19,251
-1.6%
0.01%
-61.5%
Q3 2015$1,799,000
+12.5%
19,559
+7.5%
0.01%
+18.2%
Q2 2015$1,599,000
+12.1%
18,198
-5.3%
0.01%
+10.0%
Q1 2015$1,426,000
+32.5%
19,2080.0%0.01%
+42.9%
Q4 2014$1,076,000
+23.5%
19,2080.0%0.01%
+16.7%
Q3 2014$871,000
+9.6%
19,2080.0%0.01%0.0%
Q2 2014$795,000
-21.8%
19,208
+30.9%
0.01%
-14.3%
Q1 2014$1,016,000
+14.9%
14,6710.0%0.01%
+16.7%
Q4 2013$884,000
+12.3%
14,671
+13.3%
0.01%0.0%
Q3 2013$787,000
+7.5%
12,949
+18.5%
0.01%0.0%
Q2 2013$732,00010,9250.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders